James Investment Research’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

James Investment Research’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-19,959	Closed	-$918K	–	590
2016 Q3	$918K	Sell	19,959 -15,995	-44%	-$835K	0.02%	255
2016 Q2	$1.81M	Sell	35,954 -21,555	-37%	-$1.15M	0.05%	206
2016 Q1	$3.08M	Buy	57,509 +650	+1%	+$38.1K	0.08%	165
2015 Q4	$3.73M	Buy	56,859 +3,660	+7%	+$226K	0.09%	156
2015 Q3	$3M	Sell	53,199 -995	-2%	-$64.5K	0.08%	157
2015 Q2	$3.2M	Sell	54,194 -1,520	-3%	-$93.8K	0.07%	161
2015 Q1	$3.47M	Buy	55,714 +12,360	+29%	+$719K	0.08%	169
2014 Q4	$2.49M	Buy	43,354 +29,729	+218%	+$1.66M	0.07%	174
2014 Q3	$732K	Buy	+13,625	New	+$722K	0.02%	244

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

James Investment Research's TEVA Position: Q4 2016 in Review

James Investment Research sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2016, closing a stake of 19,959 shares — an estimated $918K sold.

James Investment Research first reported a position in TEVA in Q3 2014 and held it in 9 quarters. The position peaked at $3.73M in Q4 2015. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

James Investment Research reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2016 after selling out during the quarter.
James Investment Research sold 19,959 Teva Pharmaceutical Industries Limited shares in Q4 2016, an estimated $918K.
James Investment Research first reported a position in Teva Pharmaceutical Industries Limited in Q3 2014 and held it in 9 quarters.
James Investment Research's Teva Pharmaceutical Industries Limited position peaked at $3.73M in Q4 2015.
739 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2016.

Based on James Investment Research's 13F filing for Q4 2016, filed 19 Jan 2017.